SCHEMBL17425599

SCHEMBL17425599

CC1(C)c2ccccc2-c2cc(-c3cccc(-c4nc(-c5ccccc5)nc(-c5cccc6c5oc5c(-c7ccccc7)cccc56)n4)c3)ccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 7/20 0.33
PIK3CB P42338 4/20 0.33
PIK3CG P48736 4/20 0.33
PIK3CD O00329 3/20 0.33
PIK3CA P42336 3/20 0.33
ALOX5 P09917 1/20 0.33
ALDH1A1 P00352 7/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 5/20 0.32
SMN1; SMN2 Q16637 5/20 0.32
HSD17B10 Q99714 3/20 0.32
ATM Q13315 2/20 0.32
TP53 P04637 2/20 0.32
TSHR P16473 2/20 0.32
NFKB1 P19838 2/20 0.32
LMNA P02545 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17425590 0.98 ALDH1A1 (0.34) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17425725 0.97 ALDH1A1 (0.33) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL22309346 0.96 MEN1 (0.39) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17425726 0.96 ALOX5 (0.35) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17640354 0.95 ALOX5 (0.36) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17640308 0.94 ALOX5 (0.37) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17425594 0.93 PDK2 (0.34) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17640471 0.91 PRKDC (0.35) PRKDCALOX5ALDH1A1MEN1KMT2A
SCHEMBL17425539 0.91 PDK2 (0.35) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA
SCHEMBL17425668 0.91 PDK2 (0.36) PRKDCPIK3CBPIK3CGPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 US disclosed
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-28 US disclosed
EP-2966706-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2016-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OR10J3 PRKDC 4297/4885PIK3CB 4169/4885PIK3CG 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.